Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 6/20 | 0.75 |
| ▸ | NPC1 | O15118 | 6/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.67 |
| ▸ | PKM | P14618 | 2/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.67 |
| ▸ | APP | P05067 | 5/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.55 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 1/20 | 0.53 |
| ▸ | KDM5C | P41229 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2899627 | 0.91 | ALDH1A3 (0.70) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL15177306 | 0.85 | APP (0.73) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL2932154 | 0.84 | ALDH1A3 (0.79) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL1727234 | 0.84 | NPC1 (0.69) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL24320031 | 0.84 | NPC1 (0.74) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL12380446 | 0.82 | ALDH1A3 (0.75) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL13217828 | 0.82 | ALDH1A3 (0.75) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL13198289 | 0.82 | ALDH1A3 (0.75) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL13325701 | 0.81 | ALDH1A3 (0.74) | ALDH1A3NPC1RAB9AKDM4EPKM | |
| SCHEMBL13325773 | 0.81 | ALDH1A3 (1.00) | ALDH1A3NPC1RAB9AKDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | claimed |
| WO-2025003545-A1 | DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE WITH ANTI-INFLAMMATORY ACTIVITY | UNIVERSITAT DE VALÈNCIA (ES) | 2025-01-02 | — | — | WO | claimed |
| US-20100216994-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| US-20100216994-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2218464-A1 | Compounds for non-invasive measurement of aggregates of amyloid peptides | Technische Universität München (DE) | 2010-08-18 | — | — | EP | disclosed |
| EP-2216052-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| EP-2216052-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-20090252680-A1 | NOVEL COMPOUND WITH AFFINITY FOR AMYLOID | NIHON- MEDI-PHYSICS CO., LTD (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090252680-A1 | NOVEL COMPOUND WITH AFFINITY FOR AMYLOID | NIHON- MEDI-PHYSICS CO., LTD (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-2098523-A1 | NOVEL COMPOUNDS WITH AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216994-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | APBA1, APP, S100A4 | ALDH1A3 2637/4885NPC1 792/4885RAB9A 2882/4885 |
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | IL1A, IL6, IL1B | ALDH1A3 709/4885NPC1 933/4885RAB9A 1534/4885 |
| US-20090252680-A1 | NOVEL COMPOUND WITH AFFINITY FOR AMYLOID | APBA1, APP, SLC7A1 | ALDH1A3 3051/4885NPC1 222/4885RAB9A 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.